High-dose melphalan (Alkeran) and autologous stem cell transplantation are commonly incorporated into the initial line of therapy for patients newly diagnosed with multiple myeloma.
Edward A. Stadtmauer, MD
Advertisement
Articles by Edward A. Stadtmauer, MD
Advertisement
Latest Updated Articles
- Tailoring Initial Treatment for Newly Diagnosed, Transplantation-Eligible Multiple Myeloma
Published: March 15th 2010 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
2
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
3
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
4
Guess the Therapy Answer October 29, 2025
5
